Summary: In late 1994, five medical device companies, namely, Advanced Cardiovascular Systems, Inc., Devices for Vascular Intervention, Inc., Cardiac Rhythm management Business, Heart Rhythm Technologies, Inc., and Origin Medsystems, Inc., has been combined to form Guidant Corporation. Formerly a part of Eli Lilly and Company, these companies as a group were split off by Lilly to capitalize on common customers, markets, and competencies in three areas: Vascular Intervention, Cardiac Rhythm Management and Minimally Invasive Systems. Cardisc …showed first 75 words of 1901 total…

…showed last 75 words of 1901 total…D spending. 2)<Tab/>Congestive heart failure The advantage to take on this project is that it had significant potential payoff from research and development spending. The first inititive -Brady development should be dropped after the change of the strategy and the switch of the product line. In addition, it requires investing larger amounts of resource -both in research and product development and also it faced stiff competition from the other competitors.